Aandeel 603456 ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen Zhejiang Jiuzhou Pharmaceutical Co., Ltd

Aandelen

603456

CNE100001W36

slotkoers Shanghai S.E.
Andere beurzen
 00:00:00 25-04-2024 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
15,11 CNY +2,65% Intraday-grafiek van Zhejiang Jiuzhou Pharmaceutical Co., Ltd -0,07% -37,59%
24/04 Zhejiang Jiuzhou Pharmaceutical Co., Ltd rapporteert resultaten voor het eerste kwartaal eindigend op 31 maart 2024 CI
08/04 Zhejiang Jiuzhou Pharmaceutical Co., Ltd rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023 CI

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
Zhejiang Jiuzhou Pharmaceutical Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024
Zhejiang Jiuzhou Pharmaceutical Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023
Jiuzhou Pharmaceutical Gets Nod to Market Sitagliptin Metformin Tablets; Shares Drop 4%
Ruibo Pharmaceutical Co., Ltd. announced that it expects to receive CNY 300 million in funding from Zhejiang Jiuzhou Pharmaceutical Co., Ltd
Ruibo Pharmaceutical Technology Co., Ltd. announced that it expects to receive CNY 15 million in funding from Zhejiang Jiuzhou Pharmaceutical Co., Ltd
Tranche Update on Zhejiang Jiuzhou Pharmaceutical Co., Ltd's Equity Buyback Plan announced on January 5, 2024.
Jiuzhou Pharma to Build $42 Million CRO Platform in Japan
Zhejiang Jiuzhou Pharmaceutical Co., Ltd announces an Equity Buyback for CNY 100 million worth of its shares.
Zhejiang Jiuzhou Pharmaceutical Co., Ltd authorizes a Buyback Plan.
Ruibo Pharmaceutical Technology Co., Ltd. announced that it has received CNY 50 million in funding from Zhejiang Jiuzhou Pharmaceutical Co., Ltd
Zhejiang Siwei Pharmaceutical Technology Co., Ltd announced that it has received CNY 100 million in funding from Zhejiang Jiuzhou Pharmaceutical Co., Ltd
Ruibo Pharmaceutical Technology Co., Ltd. announced that it expects to receive CNY 50 million in funding from Zhejiang Jiuzhou Pharmaceutical Co., Ltd
Zhejiang Siwei Pharmaceutical Technology Co., Ltd announced that it expects to receive CNY 100 million in funding from Zhejiang Jiuzhou Pharmaceutical Co., Ltd
Zhejiang Jiuzhou Pharmaceutical Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023
Ruibo Pharmaceutical Technology Co., Ltd. announced that it has received CNY 20 million in funding from Zhejiang Jiuzhou Pharmaceutical Co., Ltd
Ruibo Pharmaceutical Technology Co., Ltd. announced that it expects to receive CNY 20 million in funding from Zhejiang Jiuzhou Pharmaceutical Co., Ltd
Jiuzhou Pharmaceutical Logs Double-Digit Growth in H1 Earnings on Expanded CDMO Operations
Zhejiang Jiuzhou Pharmaceutical Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023
Jiuzhou Pharma to Set Up Singapore Subsidiary
Ruihua Pharmaceutical Co., Ltd. announced that it has received CNY 185 million in funding from Zhejiang Jiuzhou Pharmaceutical Co., Ltd
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers 603456
  4. Nieuws Zhejiang Jiuzhou Pharmaceutical Co., Ltd
  5. Andere talen